Back to top

Image: Bigstock

Can Medifast's New Compensation Plan Accelerate Coach Growth?

Read MoreHide Full Article

Key Takeaways

  • MED's enhanced compensation plan prioritizes Executive Director development and stronger field performance.
  • Active earning coaches fell 48.7% to about 11,700 amid rapid GLP-1 adoption in traditional weight loss.
  • Average revenue per active earning coach rose 41% to $6,529, signaling improved coach productivity.

Medifast, Inc.’s (MED - Free Report) has made substantial progress by advancing several key initiatives across the business. These include the introduction of an enhanced compensation plan designed to strengthen the company’s focus on developing and expanding its network of Executive Directors, which management identifies as the single greatest driver of sustainable business growth.

The new structure was informed by the success of the EDGE program and is intended to encourage stronger leadership development across the field. By prioritizing the development of Executive Directors, the company aims to build stronger leadership capabilities and support healthier field performance. The impact of the EDGE program is reflected in the company’s field leadership progress, with the percentage of active earning coaches at the Executive Director level or above remaining above the 10% benchmark for a healthy and scalable organization.

The company ended the second quarter of 2026 with approximately 11,700 active earning coaches, down 48.7% year over year, reflecting the continued impact of rapid GLP-1 medication adoption across the traditional weight loss category. In response, MED is reshaping its coach leadership structure by deprioritizing less productive coaches and developing a network of high-performing Executive Director organizations.

Despite the decline in coach numbers, average revenue per active earning coach increased 41% to $6,529, indicating improving coach productivity both year over year and sequentially.

Overall, if the new compensation plan successfully builds a stronger base of Executive Directors and sustains the recent improvement in coach productivity, it could support coach growth over time and, in turn, help Medifast drive revenue growth.

The Zacks Rundown for MED

The company's shares have gained 9.6% in the past six months against the industry’s decline of 2.9%.

Zacks Investment Research
Image Source: Zacks Investment Research

From a valuation standpoint, MED trades at a forward price-to-sales ratio of 0.48, lower than the industry’s average of 0.83. MED currently carries a Zacks Rank #3 (Hold).

Zacks Investment Research
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for MED’s current fiscal year earnings implies a year-over-year decline of 140.2%, whereas the same for next fiscal year earnings implies 4.1% growth year over year.

Zacks Investment Research
Image Source: Zacks Investment Research

Stocks to Consider

Some better-ranked stocks have been discussed below:

Darling Ingredients Inc. (DAR - Free Report) develops, produces, and sells sustainable natural ingredients from edible and inedible bio-nutrients in North America, Europe, China, South America, and internationally. DAR currently sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

The Zacks Consensus Estimate for DAR’s current fiscal-year sales and earnings implies growth of 12.8% and 926.5%, respectively, from the year-ago actuals. DAR delivered a trailing four-quarter negative earnings surprise of 38.9%, on average.

The Chef’s Warehouse, Inc. (CHEF - Free Report) distributes specialty food and center-of-the-plate products in the United States, the Middle East, and Canada. CHEF currently carries a Zacks Rank #1.

The Zacks Consensus Estimate for CHEF’s current fiscal-year sales and earnings indicates growth of 10.6% and 33.7%, respectively, from the year-ago reported figures. CHEF delivered a trailing four-quarter earnings surprise of 30.4%, on average.

Bunzl plc (BZLFY - Free Report) , together with its subsidiaries, markets, sells and distributes fresh, frozen, and dry food and non-food products to foodservice customers in the United States. BZLFY currently carries a Zacks Rank #2 (Buy).

The Zacks Consensus Estimate for BZLFY’ current fiscal-year sales and earnings implies growth of 6.9% and 4.2%, respectively, from the year-ago actuals.

Published in